Ristocetin: A Means of Differentiating Von Willebrand’s Disease Into Two Groups

摘要: Earlier studies have shown that patients with von Willebrand’s disease are considered to normal platelets, but they lack at least one plasma protein. Results presented indicating ristocetin, known aggregate fails cause platelet aggregation in the group of exhibiting no adhesiveness. It is postulated there may be two groups within and, further, ristocetin will provide a useful approach study deficiency or abnormality disease.